News

Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.

Horizon notches blockbuster FDA approval for rare eye disease med Tepezza
Source: Fierce Pharma Published on: January 21, 2020
STAT Plus: As prescribing for ADHD stimulants rose, so did industry payments to doctors
Source: STAT News Published on: January 21, 2020
As pipeline fattens, Lilly commits $470 million for new plant with 460 jobs
Source: Fierce Pharma Published on: January 21, 2020
CDC expected to detail first U.S. case of novel virus spreading in China
Source: STAT News Published on: January 21, 2020
STAT Plus: Pharma is making some effort to fight superbugs, but progress is ‘patchy’
Source: STAT News Published on: January 21, 2020
5 biopharmas to watch as the decade's last earnings kick off
Source: BioPharma Dive Published on: January 21, 2020
BeiGene cancer drug data sets up China duel with Merck
Source: BioPharma Dive Published on: January 21, 2020
AZ, Merck match Clovis with Lynparza 'priority' boost in prostate cancer
Source: Fierce Pharma Published on: January 21, 2020
Roche, Inotrem extend collaboration on blood test for septic shock
Source: Fierce Biotech Published on: January 21, 2020
J&J scores as judge cuts $8 billion Risperdal verdict to just $6.8 million
Source: Fierce Pharma Published on: January 21, 2020
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Source: Fierce Pharma Published on: January 21, 2020
Alternate sites of care: The changing face of healthcare delivery
Source: BioPharma Dive Published on: January 21, 2020
STAT Plus: Could a drug for arthritis in dogs also fight cancer in people?
Source: STAT News Published on: January 21, 2020
GlaxoSmithKline halts Excedrin production over manufacturing stumble
Source: Fierce Pharma Published on: January 21, 2020
JPM: Merck turns to contract manufacturers to help with Gardasil supply; plans 2023 plant openings
Source: Fierce Pharma Published on: January 21, 2020